作者：国际循环网 发布于：2004-09-27
BACKGROUND: Type 2 diabetes is associated with a substantially increased risk of cardiovascular disease， but the role of lipid-lowering therapy with statins fo...
作者：国际循环网 发布于：2004-09-16
From 1600 consecutive CHD patients randomized to either form of care in the GREek Atorvastatin and CHD Evaluation Study (GREACE)， 313 had DM: 161 in the struct...
BACKGROUND: Little is known about statins in the prevention of dyslipidaemia induced renal function decline. The secondary coronary heart disease (CHD) preventi...
Objective: To compare early initiation of an intensive statin regimen with delayed initiation of a less intensive regimen in patients with ACS. Design， Setting...
OBJECTIVE: Irbesartan was renoprotective independently of its blood pressure-lowering effect in the Irbesartan in Patients With Type 2 Diabetes and Microalbumin...
作者：RossingK，ChristensenPK 发布于：2004-09-16
专家视角丨高血压管理新篇：余静教授202..
心房颤动患者和动脉粥样硬化患者磁共振..
ESC专访｜郭豫涛教授解析mAFA扩展试验结..
波兰国家注册数据：药物涂层球囊治疗冠..
京公网安备 11010502033353号 增值电信业务经营许可证:京ICP证150541号
